Last mentioned: Jun 17, 2026
Across the most recent 2 stories covering Tim Doyle — 50% positive, 50% negative sentiment, averaging 7/10 impact.
This entity profile aggregates every story where the entity meets our minimum relevance threshold before it is linked here — a story naming this entity only in passing, as competitive context for an unrelated subject, does not qualify. That threshold exists because earlier testing surfaced entity pages cluttered with tangential mentions: a story about two unrelated companies merging could otherwise populate a third company's page simply because it was named once for comparison, with no real event of its own. The timeline below reflects genuine milestones and developments specific to this entity, cross-referenced against the same source-verification standard applied to every story on this site. Sentiment measures the directional read of each development for this entity specifically, not the overall tone of the reporting, and impact weights how consequential a development is rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Employee Windfall
Details of the $300M employee share pool emerge, confirming 100+ new millionaires.
Acquisition Announced
Hims & Hers officially announces the $1.6 billion deal to acquire Eucalyptus.
GLP-1 Surge
Juniper and Pilot brands see explosive growth driven by demand for weight-loss medications.
Eucalyptus Founded
Tim Doyle launches the company, inspired by the Hims & Hers telehealth model in the US.
Startup founders and investors clash over the impact of proposed CGT reforms at a parliamentary inquiry. While venture capital body warns iconic companies would not exist, Tim Doyle believes founders will still chase moonshots but calls for protecting employee equity from higher tax.
US telehealth giant Hims & Hers has acquired Sydney-based startup Eucalyptus in a landmark $1.6 billion deal. The acquisition, fueled by a $637 million revenue run-rate and the global GLP-1 weight loss boom, has created over 100 overnight millionaires among the Australian firm's staff.
This page surfaces every story mentioning Tim Doyle across our startup coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running startup beat. Cross-entity comparisons live on our compare view.
Entities only appear on this page once the classifier scores them at a minimum 35 percent relevance to the story, filtering out passing mentions. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Tim Doyle was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |